563 related articles for article (PubMed ID: 9254279)
1. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.
Deakin FW; Simpson MD; Slater P; Hellewell JS
J Psychopharmacol; 1997; 11(2):133-42. PubMed ID: 9254279
[TBL] [Abstract][Full Text] [Related]
2. A two-process theory of schizophrenia: evidence from studies in post-mortem brain.
Deakin JF; Simpson MD
J Psychiatr Res; 1997; 31(2):277-95. PubMed ID: 9278190
[TBL] [Abstract][Full Text] [Related]
3. Dopamine, the prefrontal cortex and schizophrenia.
Knable MB; Weinberger DR
J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
5. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia.
Deakin JF; Slater P; Simpson MD; Gilchrist AC; Skan WJ; Royston MC; Reynolds GP; Cross AJ
J Neurochem; 1989 Jun; 52(6):1781-6. PubMed ID: 2566649
[TBL] [Abstract][Full Text] [Related]
6. [Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].
Heinz A; Braus DF; Romero B; Gallinat J; Puls I; Juckel G; Weinberger DR
Nervenarzt; 2004 Sep; 75(9):845-56. PubMed ID: 15372159
[TBL] [Abstract][Full Text] [Related]
7. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
8. Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication.
Hutcheson NL; Sreenivasan KR; Deshpande G; Reid MA; Hadley J; White DM; Ver Hoef L; Lahti AC
Hum Brain Mapp; 2015 Apr; 36(4):1442-57. PubMed ID: 25504918
[TBL] [Abstract][Full Text] [Related]
9. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
[TBL] [Abstract][Full Text] [Related]
10. Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia.
Heckers S; Goff D; Schacter DL; Savage CR; Fischman AJ; Alpert NM; Rauch SL
Arch Gen Psychiatry; 1999 Dec; 56(12):1117-23. PubMed ID: 10591289
[TBL] [Abstract][Full Text] [Related]
11. The frontal lobes and schizophrenia.
Weinberger DR; Aloia MS; Goldberg TE; Berman KF
J Neuropsychiatry Clin Neurosci; 1994; 6(4):419-27. PubMed ID: 7841813
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings.
Reichenberg A; Harvey PD
Psychol Bull; 2007 Sep; 133(5):833-58. PubMed ID: 17723032
[TBL] [Abstract][Full Text] [Related]
13. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms.
Sanfilipo M; Lafargue T; Rusinek H; Arena L; Loneragan C; Lautin A; Feiner D; Rotrosen J; Wolkin A
Arch Gen Psychiatry; 2000 May; 57(5):471-80. PubMed ID: 10807487
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the dorsolateral prefrontal cortex and superior temporal sulcus in impaired social perception in schizophrenia.
Shin JE; Choi SH; Lee H; Shin YS; Jang DP; Kim JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():81-8. PubMed ID: 25545410
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
Eastwood SL; Harrison PJ
Schizophr Res; 2005 Mar; 73(2-3):159-72. PubMed ID: 15653259
[TBL] [Abstract][Full Text] [Related]
16. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report.
Takahashi T; Suzuki M; Tanino R; Zhou SY; Hagino H; Niu L; Kawasaki Y; Seto H; Kurachi M
Psychiatry Res; 2007 Apr; 154(3):209-19. PubMed ID: 17321114
[TBL] [Abstract][Full Text] [Related]
17. Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia.
Simpson MD; Slater P; Deakin JF
Biol Psychiatry; 1998 Sep; 44(6):423-7. PubMed ID: 9777172
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal progression of frontal and temporal lobe changes in schizophrenia.
Cobia DJ; Smith MJ; Wang L; Csernansky JG
Schizophr Res; 2012 Aug; 139(1-3):1-6. PubMed ID: 22647883
[TBL] [Abstract][Full Text] [Related]
19. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
[TBL] [Abstract][Full Text] [Related]
20. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
